FDA Investigator Dr. Jun Liu, PhD
Dr. Jun Liu, PhD has inspections in 2 countries as of 18 May 2023. Dr. Jun Liu, PhD has collaborated with a combined 570 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
7
Last Inspection Date:
18 May 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
Japan,
United States of America
Co-Investigator(s):
Amanda L Fyles,
Bryan A Galvez,
Chen Sun, PhD,
Chikako Torgioe,
Christopher R Czajka,
Cynthia Jim, CSO,
Davinna Ligons, PhD,
Dennis Cantellops Paite,
Diane L Raccasi,
Dr. Ralph M Bernstein, PhD,
Frances Namuswe, PhD,
Ian Mcwilliams,
Ivis Lnegron Torres,
Jacek Cieslak, PhD,
Jorge L Guadalupe,
Kristen Nickens, PhD,
Lindsey Brown, PhD,
Lindsey S Fleischman,
Madushini Dharmasena, PhD,
Michael Shanks, MS,
Ramesh Potla, PhD,
Ramon A Hernandez,
Scott R Nichols, PhD,
Thao T Kwan,
Thuy T Nguyen, LCDR,
Viviana Matta,
Yi Wang, PhD,
Yun Wu, PhD,
Zachary L Stamm,
Zhong Li, PhD
Dr. Jun Liu, PhD's Documents
Publish Date | Document Type | Title |
---|---|---|
July, 2021 | FDA 483 | Daiichi Sankyo Chemical Pharma Co., Ltd.- Tatebayashi - Form 483, 2021-07-02 |
November, 2019 | FDA 483 | Daiichi Sankyo Chemical Pharma Co., Ltd. - Form 483, 2019-11-08 |
November, 2019 | FDA 483 | Daiichi Sankyo Chemical Pharma Co., Ltd.- Tatebayashi - Form 483, 2019-11-01 |
December, 2017 | FDA 483 | Kyowa Kirin Co., Ltd. - Form 483, 2017-12-21 |
July, 2021 | FDA 483 | Daiichi Sankyo Chemical Pharma Co., Ltd. - Form 483, 2021-07-09 |
January, 2023 | FDA 483 | Tanvex BioPharma USA, Inc - Form 483, 2023-01-24 |
May, 2023 | FDA 483 | WuXi Biologics Co., Ltd. - Form 483, 2023-05-09 |
November, 2023 | FDA 483 | FUJIFILM Diosynth Biotechnologies Texas, LLC - Form 483, 2023-11-07 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more